ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.5561
-0.27%
Brent Oil
83.53
-0.08%
Bitcoin
69,789.12
5.30%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSX
  6. Tetra Bio Pharma Inc (TBP)

  7. Tetra Bio Pharma Inc (TBP) Noticias

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:TBP
FechaHoraFuenteTítuloSímboloCompañía
07/03/202307:01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
07/03/202306:59PR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
10/02/202317:27PR Newswire (Canada)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
22/12/202206:41PR Newswire (Canada)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
06/12/202206:00PR Newswire (US)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
29/11/202206:00PR Newswire (US)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
18/11/202211:23PR Newswire (Canada)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
27/10/202212:57PR Newswire (US)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
11/10/202206:42PR Newswire (US)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
08/09/202206:44PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
06/09/202208:28PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202208:27PR Newswire (Canada)IIROC Trade Resumption - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202208:13PR Newswire (Canada)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
11/08/202221:19PR Newswire (US)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/08/202205:30PR Newswire (Canada)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
12/07/202206:30PR Newswire (Canada)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
06/06/202206:33PR Newswire (Canada)Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory UpdateTSX:TBPTetra Bio Pharma Inc
31/05/202209:38PR Newswire (Canada)Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special MeetingTSX:TBPTetra Bio Pharma Inc
30/05/202206:44PR Newswire (Canada)Tetra Bio-Pharma Appoints Chief Financial OfficerTSX:TBPTetra Bio Pharma Inc
18/05/202206:56PR Newswire (US)Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBDTSX:TBPTetra Bio Pharma Inc
17/05/202210:14PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of First Tranche with CannvalateTSX:TBPTetra Bio Pharma Inc
10/05/202206:00PR Newswire (US)Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD TechnologyTSX:TBPTetra Bio Pharma Inc
05/05/202205:30PR Newswire (US)Tetra Bio-Pharma and Cannvalate Enter Into PartnershipTSX:TBPTetra Bio Pharma Inc
17/03/202205:30PR Newswire (Canada)Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDATSX:TBPTetra Bio Pharma Inc
08/03/202205:30PR Newswire (US)Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBDTSX:TBPTetra Bio Pharma Inc
28/02/202218:49PR Newswire (Canada)Tetra Bio-Pharma Provides Management UpdateTSX:TBPTetra Bio Pharma Inc
22/02/202205:30PR Newswire (US)Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary SupplementTSX:TBPTetra Bio Pharma Inc
16/02/202205:30PR Newswire (Canada)Tetra Bio-Pharma Receives $4.5M from the Ministère de l'Économie et de l'Innovation/Investissement QuébecTSX:TBPTetra Bio Pharma Inc
14/02/202206:00PR Newswire (US)Tetra Bio-Pharma Enters into a Strategic Partnership with AvicannaTSX:TBPTetra Bio Pharma Inc
21/12/202108:24PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of UnitsTSX:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSX:TBP

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
COIN
SOLUSD
Solana
NASDAQ
AAPL
Apple
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados